The Novel Glycolipid RC-552 Attenuates Myocardial Stunning and Reduces Infarct Size in Dogs

This publication has 18 references indexed in Scilit:

• Essential Role of Inducible Nitric Oxide Synthase in Monophosphoryl Lipid A–Induced Late Cardioprotection
  Circulation, 1999
• Chemical Synthesis of the Major Constituents ofSalmonella MinnesotaMonophosphoryl Lipid A
  Journal of Carbohydrate Chemistry, 1998
• Monophosphoryl Lipid A Induces Delayed Preconditioning Against Cardiac Ischemia-Reperfusion Injury
  Journal of Molecular and Cellular Cardiology, 1998
• Role of Inducible Nitric Oxide Synthase in Pharmacological “Preconditioning” with Monophosphoryl Lipid A
  Journal of Molecular and Cellular Cardiology, 1997
• Myocardial ischemia/reperfusion protection using monophosphoryl lipid a is abrogated by the ATP-sensitive potassium channel blocker, glibenclamide
  Cardiovascular Research, 1996
• A Single Endotoxin Challenge Induces Delayed Myocardial Protection against Infarction
  Journal of Surgical Research, 1996
• Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
  Biochemical Pharmacology, 1996
• Plasma Nitric Oxide End Products Are Increased in the Ischemic Canine Heart
  Biochemical and Biophysical Research Communications, 1995
• Pretreatment of normal humans with monophosphoryl lipid A induces tolerance to endotoxin
  Critical Care Medicine, 1995
• Neutrophil Mac-1 and MEL-14 Adhesion Proteins Inversely Regulated by Chemotactic Factors
  Science, 1989